Looking to the Future of Organ-on-Chip and Toxicity Assessment: a Regulator’s Opinion

Abstract

David R Jones talks to Francesca Lake, Managing Editor: David R Jones is an Expert Pharmaco-Toxicologist within the Licensing Division of the Medicines and Healthcare products Regulatory Agency. We met him at the Organ-on-a-chip Europe 2016 conference in Cambridge (UK), where he presented ‘A UK Regulatory View on the Acceptability of Organ on a Chip Data’.

Keywords::

• organ-on-chip
• pharmacology
• regulation
• toxicology

Disclaimer

Any opinions expressed in this presentation are my own, are not necessarily shared by other assessors at the MHRA, and cannot be considered to be UK policy. The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Medicine Ltd.

Financial & competing interests disclosure

DR Jones has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.